<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Moderate <z:hpo ids='HP_0002045'>hypothermia</z:hpo> and application of brain-derived neurotrophic factor (BDNF) have separately been identified as neuroprotective strategies in experimental <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>To assess their separate and combined effects on striatal <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> release in the hyperacute phase of <z:hpo ids='HP_0001297'>stroke</z:hpo>, we inserted microdialysis probes into the striatum of rats 2 h before permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="2" pm="."><plain>The animals (N = 28) were randomly assigned to one of four treatment strategies commencing 30 min after MCAO: (1) <z:hpo ids='HP_0002045'>hypothermia</z:hpo> at 33 degrees C (n = 7); (2) intravenous BDNF infusion [300 microg/(kg/h) for 2 h, n = 7]; (3) combination of <z:hpo ids='HP_0002045'>hypothermia</z:hpo> and BDNF (n = 7); (4) control group (saline, n = 7) </plain></SENT>
<SENT sid="3" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> size at 5 h after MCAO was assessed with the silver-staining method </plain></SENT>
<SENT sid="4" pm="."><plain>Total <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was significantly reduced in the <z:hpo ids='HP_0002045'>hypothermia</z:hpo> (202.7 +/- 3.5 mm(3), P = 0.0002) and BDNF group (206.5 +/- 6.9 mm(3), P = 0.0006) as compared to control group (254.4 +/- 9.3 mm(3)) </plain></SENT>
<SENT sid="5" pm="."><plain>In the combination group, <z:mpath ids='MPATH_124'>infarct</z:mpath> size was further reduced with overall significance in post hoc tests (157.3 +/- 6.2 mm(3), P &lt; 0.0001) </plain></SENT>
<SENT sid="6" pm="."><plain>Postischemic <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> concentrations in the control group constantly remained significantly higher than in <z:hpo ids='HP_0000001'>all</z:hpo> other treatment groups </plain></SENT>
<SENT sid="7" pm="."><plain>At 255 and 270 min after MCAO, striatal <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> in the combination group decreased significantly more than in animals treated with <z:hpo ids='HP_0002045'>hypothermia</z:hpo> or BDNF alone.Combining <z:hpo ids='HP_0002045'>hypothermia</z:hpo> and BDNF therapy in the <z:hpo ids='HP_0011009'>acute</z:hpo> stage of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> has a synergistic effect in attenuating striatal <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> release and reducing early <z:mpath ids='MPATH_124'>infarct</z:mpath> size </plain></SENT>
</text></document>